These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 12839095)

  • 21. Anabolic effects of insulin on bone suggest a role for chromium picolinate in preservation of bone density.
    McCarty MF
    Med Hypotheses; 1995 Sep; 45(3):241-6. PubMed ID: 8569546
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synergistic effects of high dietary calcium and exogenous parathyroid hormone in promoting osteoblastic bone formation in mice.
    Feng Y; Zhou M; Zhang Q; Liu H; Xu Y; Shu L; Zhang J; Miao D; Ren Y
    Br J Nutr; 2015 Mar; 113(6):909-22. PubMed ID: 25744000
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The potential of parathyroid hormone as a therapy for osteoporosis.
    Rubin MR; Bilezikian JP
    Int J Fertil Womens Med; 2002; 47(3):103-15. PubMed ID: 12081255
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Harnessing the parathyroids to create stronger bones.
    Silver J; Bushinsky D
    Curr Opin Nephrol Hypertens; 2004 Jul; 13(4):471-6. PubMed ID: 15199299
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Loss of Gsα in the Postnatal Skeleton Leads to Low Bone Mass and a Blunted Response to Anabolic Parathyroid Hormone Therapy.
    Sinha P; Aarnisalo P; Chubb R; Poulton IJ; Guo J; Nachtrab G; Kimura T; Swami S; Saeed H; Chen M; Weinstein LS; Schipani E; Sims NA; Kronenberg HM; Wu JY
    J Biol Chem; 2016 Jan; 291(4):1631-1642. PubMed ID: 26598522
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Parathyroid and bone. Evidence and perspective of parathyroid therapy for patients with osteoporosis].
    Wada S; Fukawa T; Kamiya S
    Clin Calcium; 2007 Dec; 17(12):1888-94. PubMed ID: 18057665
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Short-term changes in bone turnover markers and bone mineral density response to parathyroid hormone in postmenopausal women with osteoporosis.
    Bauer DC; Garnero P; Bilezikian JP; Greenspan SL; Ensrud KE; Rosen CJ; Palermo L; Black DM
    J Clin Endocrinol Metab; 2006 Apr; 91(4):1370-5. PubMed ID: 16449339
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Bone and hormones. Effects of parathyroid hormone on the bone].
    Chevalley T; Rizzoli R
    Presse Med; 1999 Mar; 28(10):547-53. PubMed ID: 10209548
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combination/sequential therapy in osteoporosis.
    Lecart MP; Bruyere O; Reginster JY
    Curr Osteoporos Rep; 2004 Dec; 2(4):123-30. PubMed ID: 16036093
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic potential of parathyroid hormone.
    Cosman F; Lindsay R
    Curr Osteoporos Rep; 2004 Mar; 2(1):5-11. PubMed ID: 16036076
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential transcriptional effects of PTH and estrogen during anabolic bone formation.
    von Stechow D; Zurakowski D; Pettit AR; Müller R; Gronowicz G; Chorev M; Otu H; Libermann T; Alexander JM
    J Cell Biochem; 2004 Oct; 93(3):476-90. PubMed ID: 15372627
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeted inhibition of sclerostin for post-menopausal osteoporosis therapy: A critical assessment of the mechanism of action.
    Bhattacharyya S; Pal S; Chattopadhyay N
    Eur J Pharmacol; 2018 May; 826():39-47. PubMed ID: 29476877
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ALX 111: ALX1-11, parathyroid hormone (1-84) - NPS Allelix, PREOS, PTH, recombinant human parathyroid hormone, rhPTH (1-84).
    Adis International Ltd
    Drugs R D; 2003; 4(4):231-5. PubMed ID: 12848587
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intermittent parathyroid hormone therapy to increase bone formation.
    Thomas T
    Joint Bone Spine; 2006 May; 73(3):262-9. PubMed ID: 16563840
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Treatment of osteoporosis with parathyroid hormone].
    Syversen U; Halse JI
    Tidsskr Nor Laegeforen; 2008 Jan; 128(1):39-41. PubMed ID: 18183056
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Parathyroid hormone(1-84) treatment of postmenopausal women with low bone mass receiving hormone replacement therapy.
    Fogelman I; Fordham JN; Fraser WD; Spector TD; Christiansen C; Morris SA; Fox J
    Calcif Tissue Int; 2008 Aug; 83(2):85-92. PubMed ID: 18626566
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The roles of parathyroid hormone in bone remodeling: prospects for novel therapeutics.
    Lombardi G; Di Somma C; Rubino M; Faggiano A; Vuolo L; Guerra E; Contaldi P; Savastano S; Colao A
    J Endocrinol Invest; 2011 Jul; 34(7 Suppl):18-22. PubMed ID: 21985975
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The rhPTH (1-34), but not elcatonin, increases bone anabolic efficacy in postmenopausal women with osteoporosis.
    Zhang L; Yang M; Liu D; Guo C; Li L; Yang G
    Exp Clin Endocrinol Diabetes; 2012 Jun; 120(6):361-6. PubMed ID: 22639400
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Catabolic and anabolic actions of parathyroid hormone on the skeleton.
    Silva BC; Costa AG; Cusano NE; Kousteni S; Bilezikian JP
    J Endocrinol Invest; 2011 Nov; 34(10):801-10. PubMed ID: 21946081
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of postmenopausal women with osteoporosis with PTH(1-84) for 36 months: treatment extension study.
    Zanchetta JR; Bogado CE; Cisari C; Aslanidis S; Greisen H; Fox J; Lems W
    Curr Med Res Opin; 2010 Nov; 26(11):2627-33. PubMed ID: 20923256
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.